FDA Approved: NEORAL — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for NEORAL (cyclosporine) from Novartis Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection Prophylaxis
• Kidney Transplant Rejection Prophylaxis
• Liver Transplant Rejection Prophylaxis
• Organ Transplantation

Drugs mentioned

• NEORAL (CYCLOSPORINE)

Snippet

SUPPL AP for NEORAL (CYCLOSPORINE)